Transcatheter Embolization And Occlusion Devices Market Outlook 2026–2030: Growth Trends, Market Dynamics And Emerging Opportunities

Transcatheter Embolization And Occlusion Devices Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Transcatheter Embolization And Occlusion Devices Market Size Forecast: How Big Could The Market Get By 2030?

The transcatheter embolization and occlusion devices market has seen swift expansion in recent years. Its valuation is forecast to climb from $5.23 billion in 2025 to $5.79 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.6%. This historical growth can be ascribed to several factors, including the increased number of interventional radiology procedures, the rising frequency of vascular disorders, improved accessibility to catheter-based therapies, a growing preference for minimally invasive treatments, and advancements in imaging-guided intervention methods.

The transcatheter embolization and occlusion devices market size is expected to experience substantial growth in the coming years. It is projected to expand to $8.33 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This anticipated growth during the forecast period can be attributed to an increasing demand for targeted embolization therapies, the rising adoption of advanced embolic materials, the expansion of oncology and neurointerventional procedures, a growing focus on precision medicine, and increasing investments in interventional healthcare infrastructure. Key trends for the forecast period include the increasing adoption of minimally invasive embolization procedures, a rising demand for advanced liquid embolic agents, the growing use of detachable and coated coils, the expansion of image-guided interventional techniques, and an enhanced focus on precision occlusion technologies.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=43905700&type=smp&name=Transcatheter%20Embolization%20And%20Occlusion%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Transcatheter Embolization And Occlusion Devices Market Expansion Drivers: What’s Shaping Future Growth?

The burgeoning demand for minimally invasive surgical methods is anticipated to drive expansion in the transcatheter embolization and occlusion devices market moving forward. These surgical procedures utilize small incisions or robotic assistance to reach internal organs, thereby reducing tissue damage, leading to less trauma, quicker recovery periods, diminished postoperative discomfort, and a decreased likelihood of complications. The rising inclination towards these interventions stems from progress in surgical technology, heightened patient understanding of less-invasive choices, and superior clinical results. Transcatheter embolization and occlusion devices facilitate such minimally invasive approaches by providing precise, catheter-based treatment with minimal disturbance to adjacent tissues. For example, in January 2025, Intuitive Surgical, Inc., a US-based medical technology corporation, reported that full-year 2024 worldwide da Vinci procedures saw an increase of approximately 17% when contrasted with 2023. The firm projects full-year 2025 worldwide da Vinci procedures to grow by approximately 13% to 16% compared with 2024. Consequently, the rising uptake of minimally invasive techniques is fueling the growth of the transcatheter embolization and occlusion devices market.

Transcatheter Embolization And Occlusion Devices Market Segmentation And Category Overview

The transcatheter embolization and occlusion devices market covered in this report is segmented –

1) By Type: Coil, Non-Coil

2) By Application: Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications

3) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users

Subsegments:

1) By Coil: Bare Metal Coil, Surface Coated Coil, Detachable Coil

2) By Non-Coil: Gelatin Sponge, Liquid Embolic Agents, Spheres And Particles

Transcatheter Embolization And Occlusion Devices Market Strategic Trends: What Defines The Next Growth Phase?

Leading firms within the transcatheter embolization and occlusion devices market are concentrating on creating sophisticated offerings, like liquid embolic systems, to satisfy the increasing need for minimally invasive vascular procedures and efficient management of arterial bleeding. Such a system constitutes a non-stick, polymer-derived embolization technique, administered via a microcatheter, which hardens when it encounters blood. This allows for precise blockage of anomalous or compromised vessels, providing superior penetration and accuracy compared to conventional coil techniques. As an illustration, in July 2025, Medtronic plc., a US medical technology corporation, introduced the Onyx Liquid Embolic System (LES) for clinical assessment via its IDE study, targeting the embolization of arterial hemorrhage within the peripheral vasculature. This novel solution employs an ethylene-vinyl alcohol (EVOH) copolymer dissolved in DMSO and combined with tantalum powder to ensure radiopacity, facilitating real-time visualization and regulated delivery by physicians. A coherent embolus is formed as the solvent spreads, leading to focused vessel blockage with a lower likelihood of catheter entrapment and enhanced safety in intricate anatomical structures. Intended for application in ongoing peripheral arterial bleeding, the system boosts accuracy, facilitates minimally invasive treatment procedures, and broadens the range of therapeutic choices available to interventional experts.

Transcatheter Embolization And Occlusion Devices Market Company Landscape And Competitive Strategy

Major companies operating in the transcatheter embolization and occlusion devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Cordis Corporation, pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc., Balt Group, Kaneka Medix Corporation, Shape Memory Medical Inc., Boston Scientific Neurovascular

View The Full Transcatheter Embolization And Occlusion Devices Market Report:

https://thebusinessresearchcompany.com/report/transcatheter-embolization-and-occlusion-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Transcatheter Embolization And Occlusion Devices Market Largest Region: Which Geography Holds The Biggest Share?

North America was the largest region in the transcatheter embolization and occlusion devices market in 2025. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model